অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ceftazidime pentahydrate, quantity: 2.328 g - injection, powder for - excipient ingredients: sodium carbonate - ceftazidime viatris is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime, and as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other pseudomonal antibiotics cannot be used.. indications include:. severe infections in general: for example septicaemia, including neonatal sepsis, bacteraemia, and in patients in intensive care units with specific problems, eg, infected burns.. respiratory tract infections: for example, pneumonia, broncho-pneumonia, infected pleurisy, infected bronchiectasis and bronchitis.. severe ear, nose and throat infections: for example, otitis media, mastoiditis.. urinary tract infections: for example, acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only), and infections associated with bladder and renal stones.. skin and soft tissue infections: for example, erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis.. gastrointestinal and abdominal infections: for example, intra-abdominal abscesses, enterocolitis.. bone and joint infections: for example, osteitis, osteomyelitis, septic arthritis, infected bursitis.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ceftazidime pentahydrate, quantity: 1.164 g - injection, powder for - excipient ingredients: sodium carbonate - ceftazidime viatris is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime, and as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other pseudomonal antibiotics cannot be used.. indications include:. severe infections in general: for example septicaemia, including neonatal sepsis, bacteraemia, and in patients in intensive care units with specific problems, eg, infected burns.. respiratory tract infections: for example, pneumonia, broncho-pneumonia, infected pleurisy, infected bronchiectasis and bronchitis.. severe ear, nose and throat infections: for example, otitis media, mastoiditis.. urinary tract infections: for example, acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only), and infections associated with bladder and renal stones.. skin and soft tissue infections: for example, erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis.. gastrointestinal and abdominal infections: for example, intra-abdominal abscesses, enterocolitis.. bone and joint infections: for example, osteitis, osteomyelitis, septic arthritis, infected bursitis.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 46777 - abdominal aortic aneurysm stent - the stent graft system when placed within the target lesion, provides a permanent, alternative conduit for blood flow within the patient's vasculature by excluding the lesion from blood flow and pressure. the stent graft is preloaded into the delivery system and advanced to the aneurysm using fluoroscopic guidance. upon deployment, the stent graft self-expands to conform to the shape and size of the seal zones above and below the aneurysm. the device is a graft system indicated for the endovascular treatment of infrarenal or juxtarenal aortic or aortoiliac aneurysms (with the parallel graft technique) in patients with the following characteristics - adequate iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, or accessories; iliac distal fixation length of ?15 mm; iliac diameters with a range of 8 to 25 mm; morphology suitable for aneurysm repair; one of the following: aneurysm diameter >5 cm or aneurysm diameter of 4 to 5 cm, which has also increased in size by 0.5 cm in the last 6 months or aneurysm that is at least 1.5 times the diameter of the normal infrarenal aorta. in addition, for treatment of infrarenal abdominal aortic or aortoiliac aneurysms, the following patient characteristics apply: proximal neck length of ?10 mm or ?4 mm and <10 mm when used in conjunction with the heli-fx endoanchor system, with insignificant calcification, or insignificant thrombus with ?60? infrarenal and ?45? suprarenal angulation and a vessel diameter approximately 10% to 20% smaller than the labeled endurant ii/iis stent graft diameter.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 46777 - abdominal aortic aneurysm stent - the stent graft system when placed within the target lesion, provides a permanent, alternative conduit for blood flow within the patient's vasculature by excluding the lesion from blood flow and pressure. the stent graft is preloaded into the delivery system and advanced to the aneurysm using fluoroscopic guidance. upon deployment, the stent graft self-expands to conform to the shape and size of the seal zones above and below the aneurysm. the device is a graft system indicated for the endovascular treatment of infrarenal or juxtarenal aortic or aortoiliac aneurysms (with the parallel graft technique) in patients with the following characteristics - adequate iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, or accessories; iliac distal fixation length of ?15 mm; iliac diameters with a range of 8 to 25 mm; morphology suitable for aneurysm repair; one of the following: aneurysm diameter >5 cm or aneurysm diameter of 4 to 5 cm, which has also increased in size by 0.5 cm in the last 6 months or aneurysm that is at least 1.5 times the diameter of the normal infrarenal aorta. in addition, for treatment of infrarenal abdominal aortic or aortoiliac aneurysms, the following patient characteristics apply: proximal neck length of ?10 mm or ?4 mm and <10 mm when used in conjunction with the heli-fx endoanchor system, with insignificant calcification, or insignificant thrombus with ?60? infrarenal and ?45? suprarenal angulation and a vessel diameter approximately 10% to 20% smaller than the labeled endurant ii/iis stent graft diameter.

তাঞ্জানিয়া - ইংরেজি - Tanzania Medicinces & Medical Devices Authority

hasafa health sciences limited, tanzania - neoprene abdominal support -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

w l gore & associates (australia) pty ltd - 46777 - abdominal aortic aneurysm stent - the gore? excluder? conformable aaa endoprosthesis is a single-use, permanently implanted device for the treatment of abdominal aortic aneurysm (aaa), an enlargement of the aorta caused by a weakening of the artery wall. the gore? excluder? conformable aaa endoprosthesis may be used to accommodate specific anatomy of an aneurysm. the gore? excluder? conformable aaa endoprosthesis is intended to exclude the aneurysm from the blood circulation in patients diagnosed with infrarenal abdominal aortic aneurysm (aaa) disease and who have appropriate anatomy as described below: ? adequate iliac / femoral access ? infrarenal aortic neck treatment diameter range of 16?32 mm ? a minimum aortic neck length of 10 mm when proximal aortic neck angulation is less than or equal to 60 degrees ? a minimum aortic neck length of 15 mm when proximal aortic neck angulation is less than or equal to 90 degrees ? iliac artery treatment diameter range of 8?25 mm and iliac distal vessel seal zone length of at least 10 mm

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - 44756 - abdominal hernia surgical mesh, composite-polymer - ultrapro advanced? mesh is a partially absorbable mesh that is used for abdominal wall hernias, providing physical reinforcement. the mechanism of action is mechanical, being used in both open and laparoscopic procedures. ultrapro advanced mesh is indicated for the repair of abdominal wall hernias that require the addition of a reinforcing material to obtain the desired surgical result.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - 44756 - abdominal hernia surgical mesh, composite-polymer - ultrapro? is a partially absorbable mesh that is used for abdominal wall hernias, providing physical reinforcement. the mechanism of action is mechanical, being used in both open and laparoscopic procedures. ultrapro mesh is indicated for the repair of abdominal wall hernias that require the addition of a reinforcing material to obtain the desired surgical result.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - 60300 - abdominal hernia surgical mesh, synthetic polymer - prolene? mesh is a sterile synthetic mesh device composed of non-absorbable undyed polypropylene fiber. the device serves as reinforcing material in the surgical treatment of abdominal wall hernias that require a reinforcing material prolene? mesh is indicated for the repair of abdominal wall hernias that require the addition of a reinforcing material to obtain the desired surgical result.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - 60300 - abdominal hernia surgical mesh, synthetic polymer - prolene? soft polypropylene mesh is a sterile synthetic mesh device composed of non-absorbable dyed and undyed polypropylene fibers. the device serves as reinforcing material in the surgical treatment of abdominal wall hernias that require a reinforcing material. prolene? soft polypropylene mesh is indicated for the repair of abdominal wall hernias that require the addition of a reinforcing material to obtain the desired surgical result